Company / Capital Expenditures
Haemonetics Capital Expenditures History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$38.1M
FY2026
5-year range
$38.1M / $191.3M
FY2022-FY2026
Trend
-
vs FY2025
Sector context
#87 of 151
Health Care
What the data says
At $38M, Haemonetics's capital expenditures ranks #87 of 151 in the Health Care sector. Capital Expenditures has fluctuated over the past 9 years, ranging from $37M in FY2020 to $191M in FY2022.
Based on SEC 10-K filings.
$38M in FY2026 with a 5-year CAGR of -17.0%.
Remained stable around $38M over the past 3 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +0.0%
- 5-Year CAGR
- -17.0%
- 10-Year CAGR
- -
Sector benchmark
#87 of 151 in Health CareTop 58% of 151This company $38.1M Sector average $271.7M
▼
-86.0% below sector average
Key checks
Key Insights
- 5-year CAGR of -17.0%, indicating a declining trend.
- Ranks #87 out of 151 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2022.
- Lowest capital expenditures in the period was in FY2020.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $38.1M | - |
| FY2025 | - | - |
| FY2024 | $39.3M | +3.0% |
| FY2023 | $38.1M | -80.1% |
| FY2022 | $191.3M | +98.2% |
| FY2021 | $96.5M | +160.6% |
| FY2020 | $37.0M | -24.0% |
| FY2019 | $48.8M | -59.0% |
| FY2018 | $119.0M | +59.0% |
| FY2017 | $74.8M | -1.8% |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026